28.06.2020, 1411 Zeichen
Zumtobel: The lightning company Zumtobel Group generated revenue growth of 1.5% up to and including February, meaning the first 10 months of 2019/20, but the worldwide restrictions to contain the pandemic led to a year-on-year decline of 2.6% to Euro 1,131.3 mn (FX-adjusted: minus 3.1%) for the full financial year. The Group’s most important markets – Great Britain, France and Italy – were particularly hard hit by the crisis. The Lighting segment, in particular, was faced with a foreign exchange-adjusted revenue decline of 3.8%. However, the results for 2019/20 clearly show the positive effects from the continued pursuit of restructuring measures which also included the reorganisation of sales in the European core markets. Revenue growth was substantially slowed by the recent crisis, but the company reached an important milestone in the development of operating profit: Group EBIT, adjusted for special effects, rose by 95% to EUR 53.9 mn in 2019/20 (2018/19: Euro 27.6 mn). The adjusted EBIT margin increased from 2.4% to 4.8% and now lies at the upper end of the forecast 3% to 5% target range. The earnings improvement was also achieved by successful cost savings measures; for example, selling and administrative costs were reduced by 5.6% during the past financial year.
Zumtobel: weekly performance:
(From the 21st Austria weekly https://www.boerse-social.com/21staustria (25/06/2020)
kapitalmarkt-stimme.at daily voice 10/365: Ganzjährige Begleitung eines Aktienportfolio-Managers (unser Financial Literacy Projekt #1)
Aktien auf dem Radar:Austriacard Holdings AG, RHI Magnesita, EuroTeleSites AG, Flughafen Wien, AT&S, Mayr-Melnhof, Kapsch TrafficCom, Polytec Group, Erste Group, Österreichische Post, Verbund, EVN, Wienerberger, voestalpine, FACC, Frequentis, Andritz, Palfinger, Cleen Energy, Heid AG, Oberbank AG Stamm, Rosenbauer, Athos Immobilien, Pierer Mobility, Agrana, Amag, OMV, Telekom Austria, Uniqa, VIG.
Marinomed
Erforscht und entwickelt völlig neuartige Technologieplattformen, die innovative Therapien gegen Atemwegs- und Augenerkrankungen ermöglichen. Aus wissenschaftlichen Ideen werden so neue Patente, Marken und Produkte geschaffen.
>> Besuchen Sie 68 weitere Partner auf boerse-social.com/partner
Die Useletter "Morning Xpresso" und "Evening Xtrakt" heben sich deutlich von den gängigen Newslettern ab.
Beispiele ansehen bzw. kostenfrei anmelden. Wichtige Börse-Infos garantiert.
Newsletter abonnieren
Infos über neue Financial Literacy Audio Files für die Runplugged App
(kostenfrei downloaden über http://runplugged.com/spreadit)
per Newsletter erhalten